Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Cancer Therapeutics|November 9, 2012
A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicityJohn E Weldon, Laiman Xiang, Jingli Zhang, et al.Reproduction (Cambridge, England)|March 31, 2005
The PATE gene is expressed in the accessory tissues of the human male genital tract and encodes a secreted sperm-associated proteinAngel A Soler-García, Rangan Maitra, Vasantha Kumar, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostateTapan K Bera, Sudipto Das, Hiroshi Maeda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISAMasanori Onda, Mark Willingham, Satoshi Nagata, et al.Proceedings of the National Academy of Sciences of the United States of America|December 6, 2012
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin ARonit Mazor, Aaron N Vassall, Jaime A Eberle, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patientsMasanori Onda, Satoshi Nagata, David J FitzGerald, et al.Proceedings of the National Academy of Sciences of the United States of America|May 5, 2022
Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelinXiufen Liu, Masanori Onda, Nathan Watson, et al.Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopesRonit Mazor, Jaime A Eberle, Xiaobo Hu, et al.Bioconjugate Chemistry|March 10, 2007
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in miceDavid Filpula, Karen Yang, Amartya Basu, et al.Pageof 2